$5.50
+ $0.10 (1.85%)
End-of-day quote: 01/12/2023
NasdaqGM:CVAC

CureVac N.V. Annual Report

Year Year 2022 2021 2020 2019
Rev. Revenue
$67.42M $102.99M $48.87M $17.42M
Rev. Revenue
$67.42M $102.99M $48.87M $17.42M
GM % Gross Margin %
-135.79% -109.02% 71.10% -59.72%
OI Operating Income
$-226.34M $-1030.35M $-133.55M $-104.88M
OM Operating Margin
0.00% 0.00% -273.27% 0.00%
NI Net Income
$-249.03M $-411.72M $-129.12M $-99.87M
EPS Earnings Per Share
$-1.32 $-4.18 $-0.98 $-1.03
Div. Dividends
$0.00 $0.00 $0.00 $0.00
PR % Payout Ratio %
0 0 0 0
Sha. Shares
194.95m 187.12m 180.46m 96.69m
OCF Operating Cash Flow
$-286.18M $-733.13M $522.40M $-86.96M
CS Cap Spending
$-36.33M $-124.22M $-36.33M $-11.17M
FCF Free Cash Flow
$-322.51M $-857.35M $486.07M $0.00M
FCFS Free Cash Flow Per Share
$-2.01 $-4.63 $3.59 $-1.03